DAUNOMYCIN AND ARACYTIN CHANGE C-MYC ONCOGENE TRANSCRIPTS IN HUMAN ERYTHROLEUKEMIC CELL-LINE DURING CELLULAR-DIFFERENTIATION

被引：0
作者：
TONINI, GP
PARODI, MT
BLASI, E
GRONBERG, A
VARESIO, L
机构：
[1] NCI, DIV CANC TREATMENT, BIOL RESPONSE MODIFIERS PROGRAM, MOLEC IMMUNOL LAB, FREDERICK, MD 21701 USA
[2] G GASLINI CHILDRENS HOSP, PAEDIAT ONCOL RES LAB, GENOA, ITALY
来源：
INTERNATIONAL JOURNAL OF IMMUNOTHERAPY | 1987年 / 3卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：185 / 190
页数：6
相关论文
共 50 条
[41]   AMPLIFICATION AND INCREASED EXPRESSION OF C-MYC PROTOONCOGENE IN THE HUMAN PROSTATIC-CARCINOMA CELL-LINE - LNCAP [J].
NAG, A ;
SMITH, RG .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, :76-76
[42]   EXPRESSION OF C-MYC ONCOGENE IN HUMAN-FIBROBLASTS DURING INVITRO SENESCENCE [J].
DEAN, R ;
KIM, SS ;
DELGADO, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 135 (01) :105-109
[43]   AP-1 C-JUN AND C-MYC REGULATION DURING MEGAKARYOCYTIC DIFFERENTIATION OF A HUMAN BI-POTENTIAL GROWTH-FACTOR-DEPENDENT CELL-LINE [J].
DERIGS, HG ;
MORGAN, DA ;
HOFFMAN, R ;
LITZ, SL ;
SROUR, EF ;
BRANDT, JE ;
BOSWELL, HS .
PLATELETS, 1995, 6 (01) :24-30
[44]   HUMAN C-MYC ONCOGENE PROTEIN IN ACTIVATED LYMPHOCYTES AND CELL-LINES [J].
SPILLER, DG ;
CHAPMAN, AF ;
TIDD, DM ;
WARENIUS, HM .
BRITISH JOURNAL OF CANCER, 1989, 60 (03) :480-481
[45]   THE HUMAN MYELOMA CELL-LINE LP-1 - A VERSATILE MODEL IN WHICH TO STUDY EARLY PLASMA-CELL DIFFERENTIATION AND C-MYC ACTIVATION [J].
PEGORARO, L ;
MALAVASI, F ;
BELLONE, G ;
MASSAIA, M ;
BOCCADORO, M ;
SAGLIO, G ;
GUERRASIO, A ;
BENETTON, G ;
LOMBARDI, L ;
CODA, R ;
AVANZI, GC .
BLOOD, 1989, 73 (04) :1020-1027
[46]   CHANGES IN SENSITIVITY TO ANTICANCER DRUGS DURING TPA-INDUCED CELLULAR-DIFFERENTIATION IN A HUMAN T-LYMPHOBLASTOID CELL-LINE (MOLT-4) [J].
TAKIMOTO, T ;
KUBOTA, M ;
TSURUTA, S ;
KITOH, T ;
TANIZAWA, A ;
AKIYAMA, Y ;
KIRIYAMA, Y ;
MIKAWA, H .
LEUKEMIA, 1988, 2 (07) :443-446
[47]   ERYTHROID-DIFFERENTIATION AND MODULATION OF C-MYC EXPRESSION INDUCED BY ANTINEOPLASTIC DRUGS IN THE HUMAN-LEUKEMIC CELL-LINE K562 [J].
TONINI, GP ;
RADZIOCH, D ;
GRONBERG, A ;
CLAYTON, M ;
BLASI, E ;
BENETTON, G ;
VARESIO, L .
CANCER RESEARCH, 1987, 47 (17) :4544-4547
[48]   EXPRESSION OF C-MYC ONCOGENE DURING DIFFERENTIATION OF HUMAN BURST-FORMING UNIT, ERYTHROID (BFU-E) [J].
UMEMURA, T ;
UMENE, K ;
NISHIMURA, J ;
FUKUMAKI, Y ;
SAKAKI, Y ;
IBAYASHI, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 135 (02) :521-526
[49]   C-MYC ANTISENSE TRANSCRIPTS ACCELERATE DIFFERENTIATION AND START APOPTOSIS IN HUMAN LEUKEMIA-CELLS [J].
HAO, XJ ;
TANG, PH ;
DU, DL ;
MAO, M ;
WU, M .
EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) :888-888
[50]   C-MYC ONCOGENE IS REARRANGED IN A HUMAN-PLASMA CELL (PC) LEUKEMIA-CELL LINE (ARH-77) [J].
NARNI, F ;
SELVANAYAGAM, P ;
BARLOGIE, B ;
DREWINKO, B ;
SAUNDERS, GF ;
ANDERSON, MD .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR) :66-66
12345